IGF2BP2 has been identified as a key regulator of stem-like, tumorigenic properties in hepatocellular carcinoma (HCC), glioblastoma, osteosarcoma, CRC, acute myeloid leukemia (AML), and other cancers [81,83]. This evidence concerns the gene IGF2BP2 and acute myeloid leukemia.